Home > Publications Database > Association of latent factors of neuroinflammation with Alzheimer's disease pathology and longitudinal cognitive decline. > print |
001 | 267052 | ||
005 | 20240826165953.0 | ||
024 | 7 | _ | |a 10.1002/dad2.12510 |2 doi |
024 | 7 | _ | |a pmid:38213951 |2 pmid |
024 | 7 | _ | |a pmc:PMC10781650 |2 pmc |
024 | 7 | _ | |a altmetric:158283574 |2 altmetric |
037 | _ | _ | |a DZNE-2024-00061 |
041 | _ | _ | |a English |
082 | _ | _ | |a 610 |
100 | 1 | _ | |a Teipel, Stefan |0 P:(DE-2719)2000026 |b 0 |e First author |u dzne |
245 | _ | _ | |a Association of latent factors of neuroinflammation with Alzheimer's disease pathology and longitudinal cognitive decline. |
260 | _ | _ | |a Hoboken, NJ |c 2024 |b Wiley |
336 | 7 | _ | |a article |2 DRIVER |
336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1709908100_26560 |2 PUB:(DE-HGF) |
336 | 7 | _ | |a ARTICLE |2 BibTeX |
336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
520 | _ | _ | |a We investigated the association of inflammatory mechanisms with markers of Alzheimer's disease (AD) pathology and rates of cognitive decline in the AD spectrum.We studied 296 cases from the Deutsches Zentrum für Neurodegenerative Erkrankungen Longitudinal Cognitive Impairment and Dementia Study (DELCODE) cohort, and an extension cohort of 276 cases of the Alzheimer's Disease Neuroimaging Initiative study. Using Bayesian confirmatory factor analysis, we constructed latent factors for synaptic integrity, microglia, cerebrovascular endothelial function, cytokine/chemokine, and complement components of the inflammatory response using a set of inflammatory markers in cerebrospinal fluid.We found strong evidence for an association of synaptic integrity, microglia response, and cerebrovascular endothelial function with a latent factor of AD pathology and with rates of cognitive decline. We found evidence against an association of complement and cytokine/chemokine factors with AD pathology and rates of cognitive decline.Latent factors provided access to directly unobservable components of the neuroinflammatory response and their association with AD pathology and cognitive decline. |
536 | _ | _ | |a 353 - Clinical and Health Care Research (POF4-353) |0 G:(DE-HGF)POF4-353 |c POF4-353 |f POF IV |x 0 |
588 | _ | _ | |a Dataset connected to CrossRef, PubMed, , Journals: pub.dzne.de |
650 | _ | 7 | |a amyloid |2 Other |
650 | _ | 7 | |a chemokine factors |2 Other |
650 | _ | 7 | |a complement |2 Other |
650 | _ | 7 | |a endothelial function |2 Other |
650 | _ | 7 | |a microglia |2 Other |
650 | _ | 7 | |a structural equation models |2 Other |
650 | _ | 7 | |a tau |2 Other |
693 | _ | _ | |0 EXP:(DE-2719)DELCODE-20140101 |5 EXP:(DE-2719)DELCODE-20140101 |e Longitudinal Cognitive Impairment and Dementia Study |x 0 |
700 | 1 | _ | |a Dyrba, Martin |0 P:(DE-2719)2810283 |b 1 |u dzne |
700 | 1 | _ | |a Kleineidam, Luca |0 P:(DE-2719)2812139 |b 2 |u dzne |
700 | 1 | _ | |a Brosseron, Frederic |0 P:(DE-2719)2810593 |b 3 |u dzne |
700 | 1 | _ | |a Levin, Fedor |0 P:(DE-2719)2814217 |b 4 |u dzne |
700 | 1 | _ | |a Bruno, Davide |b 5 |
700 | 1 | _ | |a Buerger, Katharina |0 P:(DE-2719)2811351 |b 6 |u dzne |
700 | 1 | _ | |a Cosma, Nicoleta |0 P:(DE-HGF)0 |b 7 |
700 | 1 | _ | |a Schneider, Luisa-Sophie |0 P:(DE-HGF)0 |b 8 |
700 | 1 | _ | |a Düzel, Emrah |0 P:(DE-2719)2000005 |b 9 |u dzne |
700 | 1 | _ | |a Glanz, Wenzel |0 P:(DE-2719)2811614 |b 10 |u dzne |
700 | 1 | _ | |a Fliessbach, Klaus |0 P:(DE-2719)2811326 |b 11 |u dzne |
700 | 1 | _ | |a Janowitz, Daniel |0 P:(DE-2719)9002557 |b 12 |u dzne |
700 | 1 | _ | |a Kilimann, Ingo |0 P:(DE-2719)2810394 |b 13 |u dzne |
700 | 1 | _ | |a Laske, Christoph |0 P:(DE-2719)2000055 |b 14 |u dzne |
700 | 1 | _ | |a Munk, Matthias H |0 P:(DE-2719)9001516 |b 15 |u dzne |
700 | 1 | _ | |a Maier, Franziska |0 P:(DE-HGF)0 |b 16 |
700 | 1 | _ | |a Peters, Oliver |0 P:(DE-2719)2811024 |b 17 |u dzne |
700 | 1 | _ | |a Pomara, Nunzio |0 P:(DE-HGF)0 |b 18 |
700 | 1 | _ | |a Perneczky, Robert |0 P:(DE-2719)2812234 |b 19 |u dzne |
700 | 1 | _ | |a Rauchmann, Boris Stephan |0 P:(DE-2719)9001808 |b 20 |u dzne |
700 | 1 | _ | |a Priller, Josef |0 P:(DE-2719)2811122 |b 21 |u dzne |
700 | 1 | _ | |a Ramirez, Alfredo |0 P:(DE-2719)2812825 |b 22 |u dzne |
700 | 1 | _ | |a Roy, Nina |0 P:(DE-2719)2812341 |b 23 |u dzne |
700 | 1 | _ | |a Schneider, Anja |0 P:(DE-2719)2812035 |b 24 |u dzne |
700 | 1 | _ | |a Spottke, Annika |0 P:(DE-2719)2811324 |b 25 |u dzne |
700 | 1 | _ | |a Spruth, Eike Jakob |0 P:(DE-2719)2812446 |b 26 |
700 | 1 | _ | |a Roeske, Sandra |0 P:(DE-2719)2810395 |b 27 |u dzne |
700 | 1 | _ | |a Wagner, Michael |0 P:(DE-2719)2000057 |b 28 |u dzne |
700 | 1 | _ | |a Wiltfang, Jens |0 P:(DE-2719)2811317 |b 29 |u dzne |
700 | 1 | _ | |a Wolfsgruber, Steffen |0 P:(DE-2719)2810544 |b 30 |u dzne |
700 | 1 | _ | |a Bartels, Claudia |0 P:(DE-2719)9000444 |b 31 |
700 | 1 | _ | |a Jessen, Frank |0 P:(DE-2719)2000032 |b 32 |u dzne |
700 | 1 | _ | |a Heneka, Michael T |0 P:(DE-2719)2000008 |b 33 |e Last author |u dzne |
700 | 1 | _ | |a group, DELCODE study |b 34 |
700 | 1 | _ | |a Initiative, the Alzheimer´s Disease Neuroimaging |b 35 |e Collaboration Author |
773 | _ | _ | |a 10.1002/dad2.12510 |g Vol. 16, no. 1, p. e12510 |0 PERI:(DE-600)2832898-X |n 1 |p e12510 |t Alzheimer's & dementia / Diagnosis, assessment & disease monitoring |v 16 |y 2024 |x 2352-8729 |
856 | 4 | _ | |y OpenAccess |u https://pub.dzne.de/record/267052/files/DZNE-2024-00061.pdf |
856 | 4 | _ | |y OpenAccess |x pdfa |u https://pub.dzne.de/record/267052/files/DZNE-2024-00061.pdf?subformat=pdfa |
909 | C | O | |o oai:pub.dzne.de:267052 |p openaire |p open_access |p VDB |p driver |p dnbdelivery |
910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 0 |6 P:(DE-2719)2000026 |
910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 1 |6 P:(DE-2719)2810283 |
910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 2 |6 P:(DE-2719)2812139 |
910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 3 |6 P:(DE-2719)2810593 |
910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 4 |6 P:(DE-2719)2814217 |
910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 6 |6 P:(DE-2719)2811351 |
910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 9 |6 P:(DE-2719)2000005 |
910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 10 |6 P:(DE-2719)2811614 |
910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 11 |6 P:(DE-2719)2811326 |
910 | 1 | _ | |a External Institute |0 I:(DE-HGF)0 |k Extern |b 12 |6 P:(DE-2719)9002557 |
910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 13 |6 P:(DE-2719)2810394 |
910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 14 |6 P:(DE-2719)2000055 |
910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 15 |6 P:(DE-2719)9001516 |
910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 17 |6 P:(DE-2719)2811024 |
910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 19 |6 P:(DE-2719)2812234 |
910 | 1 | _ | |a External Institute |0 I:(DE-HGF)0 |k Extern |b 20 |6 P:(DE-2719)9001808 |
910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 21 |6 P:(DE-2719)2811122 |
910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 22 |6 P:(DE-2719)2812825 |
910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 23 |6 P:(DE-2719)2812341 |
910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 24 |6 P:(DE-2719)2812035 |
910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 25 |6 P:(DE-2719)2811324 |
910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 26 |6 P:(DE-2719)2812446 |
910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 27 |6 P:(DE-2719)2810395 |
910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 28 |6 P:(DE-2719)2000057 |
910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 29 |6 P:(DE-2719)2811317 |
910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 30 |6 P:(DE-2719)2810544 |
910 | 1 | _ | |a External Institute |0 I:(DE-HGF)0 |k Extern |b 31 |6 P:(DE-2719)9000444 |
910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 32 |6 P:(DE-2719)2000032 |
910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 33 |6 P:(DE-2719)2000008 |
913 | 1 | _ | |a DE-HGF |b Gesundheit |l Neurodegenerative Diseases |1 G:(DE-HGF)POF4-350 |0 G:(DE-HGF)POF4-353 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-300 |4 G:(DE-HGF)POF |v Clinical and Health Care Research |x 0 |
914 | 1 | _ | |y 2024 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2023-10-26 |
915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0112 |2 StatID |b Emerging Sources Citation Index |d 2023-10-26 |
915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b ALZH DEMENT-DADM : 2022 |d 2023-10-26 |
915 | _ | _ | |a Creative Commons Attribution-NonCommercial CC BY-NC 4.0 |0 LIC:(DE-HGF)CCBYNC4 |2 HGFVOC |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0501 |2 StatID |b DOAJ Seal |d 2021-04-16T15:13:10Z |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0500 |2 StatID |b DOAJ |d 2021-04-16T15:13:10Z |
915 | _ | _ | |a Fees |0 StatID:(DE-HGF)0700 |2 StatID |d 2023-10-26 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |d 2023-10-26 |
915 | _ | _ | |a OpenAccess |0 StatID:(DE-HGF)0510 |2 StatID |
915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b DOAJ : Anonymous peer review |d 2021-04-16T15:13:10Z |
915 | _ | _ | |a Article Processing Charges |0 StatID:(DE-HGF)0561 |2 StatID |d 2023-10-26 |
915 | _ | _ | |a IF >= 5 |0 StatID:(DE-HGF)9905 |2 StatID |b ALZH DEMENT-DADM : 2022 |d 2023-10-26 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2023-10-26 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0320 |2 StatID |b PubMed Central |d 2023-10-26 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2023-10-26 |
920 | 1 | _ | |0 I:(DE-2719)1011303 |k AG Heneka ; AG Heneka |l Neuroinflammation, Biomarker |x 0 |
920 | 1 | _ | |0 I:(DE-2719)1510100 |k AG Teipel |l Clinical Dementia Research (Rostock /Greifswald) |x 1 |
920 | 1 | _ | |0 I:(DE-2719)1011201 |k AG Wagner |l Neuropsychology |x 2 |
920 | 1 | _ | |0 I:(DE-2719)1111015 |k Clinical Research (Munich) |l Clinical Research (Munich) |x 3 |
920 | 1 | _ | |0 I:(DE-2719)5000006 |k AG Düzel |l Clinical Neurophysiology and Memory |x 4 |
920 | 1 | _ | |0 I:(DE-2719)1011101 |k Patient Studies Bonn |l Patient Studies Bonn |x 5 |
920 | 1 | _ | |0 I:(DE-2719)1210000 |k AG Gasser |l Parkinson Genetics |x 6 |
920 | 1 | _ | |0 I:(DE-2719)5000000 |k AG Peters |l Biomarker-Assisted Early Detection of Dementias |x 7 |
920 | 1 | _ | |0 I:(DE-2719)5000007 |k AG Priller |l Translational Neuropsychiatry |x 8 |
920 | 1 | _ | |0 I:(DE-2719)1110008 |k AG Simons |l Molecular Neurobiology |x 9 |
920 | 1 | _ | |0 I:(DE-2719)5000022 |k AG Dichgans |l Vascular Cognitive Impairment & Post-Stroke Dementia |x 10 |
920 | 1 | _ | |0 I:(DE-2719)1011103 |k AG Spottke |l Clinical Research (Bonn) |x 11 |
920 | 1 | _ | |0 I:(DE-2719)1011305 |k AG Schneider |l Translational Dementia Research (Bonn) |x 12 |
920 | 1 | _ | |0 I:(DE-2719)1410006 |k AG Wiltfang |l Molecular biomarkers for predictive diagnostics of neurodegenerative diseases |x 13 |
920 | 1 | _ | |0 I:(DE-2719)1011102 |k AG Jessen |l Clinical Alzheimer’s Disease Research |x 14 |
980 | _ | _ | |a journal |
980 | _ | _ | |a VDB |
980 | _ | _ | |a UNRESTRICTED |
980 | _ | _ | |a I:(DE-2719)1011303 |
980 | _ | _ | |a I:(DE-2719)1510100 |
980 | _ | _ | |a I:(DE-2719)1011201 |
980 | _ | _ | |a I:(DE-2719)1111015 |
980 | _ | _ | |a I:(DE-2719)5000006 |
980 | _ | _ | |a I:(DE-2719)1011101 |
980 | _ | _ | |a I:(DE-2719)1210000 |
980 | _ | _ | |a I:(DE-2719)5000000 |
980 | _ | _ | |a I:(DE-2719)5000007 |
980 | _ | _ | |a I:(DE-2719)1110008 |
980 | _ | _ | |a I:(DE-2719)5000022 |
980 | _ | _ | |a I:(DE-2719)1011103 |
980 | _ | _ | |a I:(DE-2719)1011305 |
980 | _ | _ | |a I:(DE-2719)1410006 |
980 | _ | _ | |a I:(DE-2719)1011102 |
980 | 1 | _ | |a FullTexts |
Library | Collection | CLSMajor | CLSMinor | Language | Author |
---|